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The cytochrome P450 enzymes are major catalysts involved in the oxidations of xenobiotic chemicals in microorganisms as well as higher animals
and plants. Because of their functional roles, they offer potential in biodegradation technology. A number of microbial P450s have already been
characterized and offer advantages in terms of their high catalytic rates and facile expression in microorganisms. One approach to extending the
catalytic selectivity to more compounds in the environment is rational design. In three cases, the three-dimensional structures of bacterial
cytochrome P450 enzymes are available and can be further understood through studies with molecular dynamics. Many mammalian cytochrome
P450 enzymes have been studied extensively and have potential for biodegradation because of their broad catalytic selectivities (e.g., P450 2E1).
Several advances have been made in the heterologous expression of these proteins in microorganisms. Improvements under development include
electron transfer from flavodoxin and the use of cytochrome P450:NADPH-cytochrome P450 reductase fusion proteins. Random mutagenesis
offers the potential of improving the catalytic activities of some of these proteins. Future challenges include the use of cytochrome P450 expression
vectors in microorganisms capable of thriving in the environment; recent success in expression of vectors in Salmonella genotoxicity tester strains
may be encouraging in this regard. - Environ Health Perspect 103(Suppl 5):25-28 (1995)
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Introduction
The cytochrome P450 enzymes are spread
through the phylogenetic spectrum and,
collectively, are major catalysts involved in
the aerobic oxidation of almost all classes
of organic molecules (for a recent review,
see the entire January 1992 issue ofFASEB
J). The list of monooxygenation reactions
that are catalyzed includes aliphatic
hydroxylation, desaturation, heteroatom
oxygenation and dealkylation, epoxidation,
oxidative group migration, and various
modes of mechanism-based inactivation
(1). Most of these different modes of oxi-
dation may be understood in terms of
some basic and common chemistry involv-
ing the activation of 02 to generate a reac-
tive FeO3+ entity, the abstraction of a
hydrogen atom or nonbonding or elec-
tron (by FeO3+), and radical recombination
(Figure 1) (2). A key to our understanding
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ofcatalytic action ofthe P450s is the view
that the FeO3+ moiety is an inherently
strong oxidant and that a great variety of
oxidation reactions are accessible to the
P450s ifthe proteins position specific moi-
eties of a compound close enough to this
entity (1). As pointed out above, the P450s
appear in most organisms, and within each
mammalian organism there are more than
40 different P450 genes expressed (4).
Collectively, several hundred P450s from
various P450s have now been characterized
at the level oftheir primary sequences (4)
so there is a wide repertoire of potential
catalysts available for biodegradation work.
Use of Natural P450s
Microbial systems are ofgreatest utility for
biodegradation work. Some bacterial and
fungal P450s have already been character-
ized and are known to degrade certain
chemicals of interest. Foremost among
these is P450 101 from Pseudomonas
putida, which has been reviewed by
Gunsalus et al. (5) and Peterson and Lu
(6). It should be pointed out however that
the list ofcharacterized bacterial and fungal
P450s is still relatively short (4) and may
not be particularly useful as a source for
future biodegradation work.
Considerable potential exists for the iso-
lation of new bacterial P450s and other
microbial P450s capable ofoxidizing par-
ticular substrates. The approach can involve
searches for growth with a particular chem-
ical as a carbon source (6). This approach
is probably most applicable with the
Pseudomonads (5).
Rational Redesign of P450s
An alternate approach is that of redesign-
ing a particular known P450 enzyme to
alter its catalytic specificity by changing
amino acids in the protein. This approach
requires knowledge of a (static) three-
dimensional structure of a protein.
Currently, only two such P450 structures
are available, the bacterial P450 101 and
102. Also of use is dynamic modeling in
which computer programs are used to pre-
dict the motion of each atom in the pro-
tein (or at least in the active site) and
project the spatial course ofthe substrate as
a function of time (usually on the order of
picoseconds).
Such an approach has been applied to
P450 101 by Paulsen et al. (7). The
approach was applied to the hydroxylation
of norcamphor, and replacement of a Tyr
residue with Phe led to decreased mobility
of the substrate and an altered pattern of
hydroxylation (7). This general approach
will have the greatest potential in cases in
which the mutants predicted to have
altered properties can be produced and
analyzed. Ofcourse, appropriate vector sys-
tems will be required to introduce such
P450s into field situations.
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Figure 1. Major oxidation reactions catalyzed by P450 enzymes. From Guengerich (3).
Heterologous Expression
of P450 Proteins
Several microbial approaches to the expres-
sion of P450s have been employed.
Bacterial P450s have been expressed in
other bacteria at higher levels (6,8), and
Candida tropicalis P450s have been
expressed in Saccharomyces cerevesiae (9).
Mammalian P450s offer some advan-
tages over the microbial P450s in terms of
development for biodegradation work. The
major advantages are that more of these
enzymes have been characterized and more
is already known about their catalytic
specificities. Some are known to be rather
nonselective in their substrate selectivity
and can process compounds that are either
small (e.g., P450 2E1) or large (e.g., P450
3A4) (10). The cDNAs are readily avail-
able since polymerase chain reaction and
other technologies can be used to rapidly
obtain the vectors from crude tissues.
However, expression in microbrial vectors
is probably essential for the development of
these proteins for biodegradation work.
There is considerable precedent for the
expression of mammalian P450s in yeast,
beginning with the work of Sakaki et al.
(11). The literature on expression of yeast
has been reviewed recently (12). The sys-
tems have some advantages; however,
Saccharomyces strains used to date are prob-
ably not suitable for transfer to the field. If
satisfactory fungal vectors and strains could
be developed, they could be considered.
Expression of enzymes in bacteria has
many advantages. Bacterial expression of
mammalian P450s was hampered by early
problems with proteolysis of NADPH-
P450 reductase (13) and problems in
expression of native P450 sequences (14).
However, with new vectors and slight
modification of5' sequences, the high level
expression of several bovine, rabbit, and
human P450s has been achieved (Table 1).
A typical Fe2` CO versus Fe2` spectrum of
human P450 3A4 produced in Escherichia
coli is shown in Figure 2. The P450s most
likely to be of value in biodegradation
studies may be P450s lAI, 1A2, 2E1, and
3A4 (Table 1); their catalytic specificities
are known in some detail. P450 lAI oxi-
dizes polycyclic hydrocarbons, P450 1A2
oxidizes aromatic amines, P450 2E1 oxi-
dizes small halocarbons and vinyl
monomers, and P450 3A4 oxidizes a num-
ber of large molecules (10). A problem
encountered in the bacterial expression of
P450s is the lack of a P450-reductase activ-
ity, although with some P450s there is
some reduction by a flavodoxin (MR
Waterman and C Jenkins, personal com-
Table 1. Mammalian P450s expressed in E co/i.a
Human Others
P450 lAl Rabbit P450 2B4
P450 1A2 Rabbit P450 2C3
P450 2C10 Rabbit P450 2E1
P450 2E1 Rat P450 7A
P450 3A4 Bovine P450 11A
P450 1 1A Bovine P450 17A
P450 17A
P450 lAl:NADPH-P450 reductase
P450 lA2:NADPH-P450 reductase
P450 3A4:NADPH-P450 reductase
"Data from Barnes et al. ( 14), Gillam et al. ( 15),
Richardson et al. (19), Wada et al. (20), Li and Chiang
(21), Larson et al. (22), Shimada et al. (23), Sandhu et
al. (24), and Fisher et al. (25).
munication). One approach to this prob-
lem would be the coexpression of
NADPH-P450 reductase using a second
plasmid; however, a more practical
approach appears to be the construction of
P450:NADPH-P450 reductase fusion pro-
teins, for which there is precedent
(16-18). Several ofthese have already been
prepared (Table 1) although their func-
tional activity in bacterial cells has not yet
been characterized.
Improvement to
P450sthrough
Random Mutagenesis
The construction of P450:NADPH fusion
proteins (Table 1), which should prove to
be active within cells, enables a number of
strategies to be considered for the improve-
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Figure 2. Fe2+ -Co vs Fe2+ difference spectrum of E.
coli membranes containing P450 3A4 expressed in the
vector pcW. The baseline is also shown From Gillam et
al. ( 15).
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ment ofthe systems. As mentioned earlier,
rational redesign can be done if three-
dimensional structures can be obtained;
however, even in the absence ofsuch infor-
mation, it is possible to consider improve-
ment ofcatalytic activities through random
mutagenesis approaches. This strategy is
particularly attractive since many of the
P450 substrates under consideration are
toxic, and screening should not be difficult.
A typical approach would involve replacing
a large segment ofthe P450 construct with
a portion in which mutations had been
randomly introduced and then transfecting
the resulting plasmid(s) into E. coli.
Colonies capable ofgrowth on high levels
of the substrate could be selected and the
cDNA recovered for analysis of the
sequence (26,27). The expressed protein
could be purified and its catalytic activity
analyzed in more detail. The same
approach could be applied to other seg-
ments ofthe P450 to obtain a more active
enzyme, which could then be used in a vec-
tor and organism more appropriate for use
in the field.
Prospects and Problems
The approaches outlined above are all tech-
nically possible today (e.g., Figure 2 and
Table 1), and only the matters ofcatalysis
within cells and improvement through ran-
dom mutagenesis remain to be achieved.
There is also hope that the general strate-
gies may be enhanced with increasing
knowledge about the characteristics of
P450s found in microorganisms, plants,
and insects where there has been consider-
able interest. The acquisition of more
three-dimensional structures will also aug-
ment the work.
Some problems do need to be overcome.
In particular, there will be a real need to
move useful P450 constructs into vectors
that can be used in the field. In the field,
there are problems with low oxygen ten-
sion, limited nutrients, etc., that will need
to be dealt with. Finally, it is unknown
what regulatory problems will arise from
the introduction of novel engineered
microorganisms into the field.
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